Avita Medical, Inc. Common Stock
RCEL Real Time Price USDRecent trades of RCEL by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by RCEL's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Tissue processing tray Aug. 01, 2023
-
Patent Title: Systems and methods for tissue processing and preparation of cell suspension therefrom Sep. 21, 2021
-
Patent Title: Cell suspension preparation technique and device Aug. 04, 2020
-
Patent Title: Cell suspension preparation technique and device Jan. 16, 2018
-
Patent Title: Cell suspension preparation technique and device Jul. 14, 2015
-
Patent Title: Cell suspension preparation technique and device May. 12, 2015
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of RCEL in WallStreetBets Daily Discussion
Recent insights relating to RCEL
Recent picks made for RCEL stock on CNBC
ETFs with the largest estimated holdings in RCEL
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RCEL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.